Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,015,870
+$137,863 QoQ
Shares Held
4,037
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,522
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Silvant Capital Management LLC holds $144,195,613 across 8 Drug Manufacturers - General names. ABBV ranks #3 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
115,077 | $138,026,817 | |
| 2 | MRK |
Merck & Co., Inc.
|
25,811 | $3,316,713 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,037 | $1,015,870 | |
| 4 | JNJ |
Johnson & Johnson
|
2,471 | $627,559 | |
| 5 | AMGN |
Amgen Inc
|
1,245 | $450,839 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,887 | $339,208 | |
| 7 | PFE |
Pfizer Inc
|
9,981 | $240,342 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,411 | $178,265 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,015,870 | 4,037 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $878,007 | 4,037 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $922,414 | 4,037 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $934,726 | 4,037 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $749,347 | 4,037 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $845,832 | 4,037 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $717,374 | 4,037 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $797,226 | 4,037 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $692,426 | 4,037 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $735,137 | 4,037 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $625,613 | 4,037 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $601,755 | 4,037 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $543,905 | 4,037 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $643,376 | 4,037 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $652,419 | 4,037 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $541,805 | 4,037 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $618,306 | 4,037 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $654,438 | 4,037 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $646,805 | 4,777 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $515,294 | 4,777 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $538,081 | 4,777 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $516,966 | 4,777 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $511,855 | 4,777 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $418,417 | 4,777 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $469,005 | 4,777 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $346,740 | 4,551 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||